CVE-2026-22168 OpenClaw < 2026.2.21 - Command Injection via cmd.exe /c Trailing Arguments in system.run

What is CVE-2026-22168?

CVE-2026-22168 is a high-severity command injection vulnerability in Openclaw Openclaw, published on 18 Mar 2026. Any signed-in user can exploit it over the network, with no action from the victim.

Official description

OpenClaw versions prior to 2026.2.21 contain an approval-integrity mismatch vulnerability in system.run that allows authenticated operators to execute arbitrary trailing arguments after cmd.exe /c while approval text reflects only a benign command. Attackers can smuggle malicious arguments through cmd.exe /c to achieve local command execution on trusted Windows nodes with mismatched audit logs.

Weakness: CWE-88

Which versions are affected by CVE-2026-22168?

2 open source packages ship an affected version, including openclaw. It affects 1 product.

Products include Openclaw Openclaw.

How do I fix CVE-2026-22168?

Upgrade openclaw to 2026.2.21 or later.

Upgrade, and pass arguments to programs as a list instead of through a shell. More about Command injection.

Is CVE-2026-22168 being exploited?

There is no known exploitation of CVE-2026-22168 in the wild and no public exploit code.

Other vulnerabilities in Openclaw Openclaw

• CVE-2026-28363 Security feature bypass in OpenClaw Critical 9.9
• CVE-2026-30741 Code injection in n/a Critical 9.8
• CVE-2026-33579 OpenClaw < 2026.3.28 - Privilege Escalation via Missing Caller Scope Validation in Device Pair Approval Critical 9.4
• CVE-2026-32922 OpenClaw < 2026.3.11 - Privilege Escalation via Unvalidated Scope in device.token.rotate Critical 9.4
• CVE-2026-32978 OpenClaw < 2026.3.11 - Approval Bypass via Unrecognized Script Runners Critical 9.4

All Openclaw Openclaw vulnerabilities

Sources

• CVE record
• NVD
• OSV
• GitHub advisory
• How this page is made

Also known as GHSA-5v6x-rfc3-7qfr, MINI-933h-g359-3h95.